Literature DB >> 8098165

Effects of dimethylthiourea on selective neuronal vulnerability in forebrain ischemia in rats.

K Pahlmark1, J Folbergrová, M L Smith, B K Siesjö.   

Abstract

BACKGROUND AND
PURPOSE: Attempts have been made to characterize conditions under which oxygen free radicals contribute to ischemic brain damage. According to one hypothesis, free radicals are likely mediators of damage only when ischemia is of such long duration that infarction develops or when either preischemic hyperglycemia or hyperthermia is present. The objective of the present study was to explore whether 15 minutes of forebrain ischemia, an insult that leads to selective neuronal vulnerability but not to infarction, is accompanied by production of pathogenetically important free radicals.
METHODS: Using a histopathological end point, we studied amelioration of damage by a free radical scavenger, dimethylthiourea, administered in a dose of 750 mg/kg i.p. 60 minutes before ischemia. To study whether this insult leads to detectable protein oxidation we assessed the activity of glutamine synthetase and of carbonyl compounds in the soluble protein fraction.
RESULTS: In control animals, the transient ischemia resulted in the expected damage to vulnerable neurons in hippocampus, caudoputamen, and neocortex after 7 days of recovery. Glutamine synthetase activity in caudoputamen and hippocampus and carbonyl content in the soluble protein fraction after 90 minutes of recovery were not affected. However, dimethylthiourea significantly reduced damage to hippocampus and caudoputamen (p < 0.001) and neocortex (p < 0.005).
CONCLUSIONS: Lack of evidence of protein oxidation supports the notion that 15 minutes of forebrain ischemia results in a limited insult, confined to the neurons. Provided that unspecific effects can be excluded, the results obtained with dimethylthiourea suggest that free radicals contribute to selective neuronal necrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098165     DOI: 10.1161/01.str.24.5.731

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  The difference in the effect of glutamate and NO synthase inhibitor on free calcium concentration and Na+, K+-ATPase activity in synaptosomes from various brain regions.

Authors:  N F Avrova; K I Shestak; I O Zakharova; T V Sokolova; V G Leont'ev
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

3.  Free radicals and brain damage due to transient middle cerebral artery occlusion: the effect of dimethylthiourea.

Authors:  Y Kiyota; K Pahlmark; H Memezawa; M L Smith; B K Siesjö
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

4.  N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia.

Authors:  J Folbergrová; Q Zhao; K Katsura; B K Siesjö
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor.

Authors:  S Cho; B T Volpe; Y Bae; O Hwang; H J Choi; J Gal; L C Park; C K Chu; J Du; T H Joh
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

6.  Hydrogen-peroxide-induced toxicity of rat striatal neurones involves activation of a non-selective cation channel.

Authors:  M A Smith; P S Herson; K Lee; R D Pinnock; M L J Ashford
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

7.  Neferine, a bisbenzylisoquinoline alkaloid, offers protection against cobalt chloride-mediated hypoxia-induced oxidative stress in muscle cells.

Authors:  Rathinasamy Baskaran; Palanisamy Kalaiselvi; Chih-Yang Huang; Viswanadha Vijaya Padma
Journal:  Integr Med Res       Date:  2015-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.